Range Low Price High Price Comment
30 days $0.300 $0.429 Thursday, 28th Mar 2024 GLMD stock ended at $0.346. This is 4.88% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 9.06% from a day low at $0.320 to a day high of $0.349.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
2024-03-28 $0.349 $0.349 $0.320 $0.346 41 109
2024-03-27 $0.320 $0.340 $0.320 $0.330 15 989
2024-03-26 $0.324 $0.327 $0.320 $0.320 45 824
2024-03-25 $0.317 $0.326 $0.302 $0.320 134 875
2024-03-22 $0.319 $0.328 $0.307 $0.311 63 713
2024-03-21 $0.305 $0.318 $0.305 $0.316 53 970
2024-03-20 $0.315 $0.320 $0.300 $0.305 78 246
2024-03-19 $0.320 $0.329 $0.303 $0.313 80 083
2024-03-18 $0.300 $0.350 $0.300 $0.311 295 239
2024-03-15 $0.410 $0.410 $0.301 $0.305 3 450 208
2024-03-14 $0.360 $0.360 $0.320 $0.349 34 062
2024-03-13 $0.370 $0.370 $0.350 $0.360 20 165
2024-03-12 $0.390 $0.390 $0.360 $0.360 34 803
2024-03-11 $0.380 $0.380 $0.368 $0.370 37 692
2024-03-08 $0.389 $0.395 $0.370 $0.380 11 800
2024-03-07 $0.388 $0.390 $0.367 $0.380 23 856
2024-03-06 $0.363 $0.381 $0.363 $0.370 47 000
2024-03-05 $0.398 $0.398 $0.350 $0.385 125 736
2024-03-04 $0.405 $0.429 $0.390 $0.391 87 072
2024-03-01 $0.419 $0.420 $0.390 $0.410 195 750
2024-02-29 $0.412 $0.412 $0.392 $0.396 103 891
2024-02-28 $0.389 $0.410 $0.375 $0.400 160 898
2024-02-27 $0.370 $0.389 $0.367 $0.384 162 731
2024-02-26 $0.360 $0.390 $0.360 $0.368 44 423
2024-02-23 $0.360 $0.365 $0.360 $0.363 31 362
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT